{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:25:35Z","timestamp":1791221135985,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2003,12,16]],"date-time":"2003-12-16T00:00:00Z","timestamp":1071532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12,16]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Autoantibodies against proteinase 3 (PR3) and myeloperoxidase (MPO) (ANCA = anti-neutrophil cytoplasmic antibodies) are used as diagnostic tools for patients with small vessel vasculitis. ANCA are detected by different assays, but the correlation between the results of these assays is generally poor. The overall aim of the study was to provide a framework for the future development of new assays with an increased diagnostic yield. In order to express discrete epitopes of human PR3 (hPR3), the nonantigenic molecules murine PR3 (mPR3) and human leucocyte elastase (HLE) were used as a framework. We constructed recombinant chimeric vectors and were able to produce 6 hPR3\/mPR3 proteins and 3 hPR3\/HLE proteins. Anti-PR3 monoclonal antibodies differed in their binding pattern to the chimeras, but no distinct binding region could be identified for any monoclonal antibody. The recombinant hPR3\/mPR3 were also tested in ELISA with sera from patients with Wegener's granulomatosis with renal involvement. The results show that patients have antibodies to different constructs, indicating that the patients vary in their antibody repertoire from the beginning of the disease, and that patients may have antibodies from a broad range of clones early in the course of the disease. Recombinant hPR3\/mPR3 chimeric proteins have a potential to be used as antigens in future ANCA assays.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2004.02314.x","type":"journal-article","created":{"date-parts":[[2003,12,16]],"date-time":"2003-12-16T16:38:20Z","timestamp":1071592700000},"page":"164-172","source":"Crossref","is-referenced-by-count":23,"title":["Epitope mapping of anti-PR3 antibodies using chimeric human\/mouse PR3 recombinant proteins"],"prefix":"10.1093","volume":"135","author":[{"given":"D","family":"SELGA","sequence":"first","affiliation":[{"name":"Department of Nephrology, Lund University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"SEGELMARK","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Lund University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"WIESLANDER","sequence":"additional","affiliation":[{"name":"Wieslab AB, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"GUNNARSSON","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Lund University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"HELLMARK","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Lund University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2003,12,16]]},"reference":[{"key":"2022011223172865900_b1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1432-1033.1973.tb02932.x","article-title":"The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases","volume":"36","author":"Ohlsson","year":"1973","journal-title":"Eur J Biochem"},{"key":"2022011223172865900_b2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jlb.61.1.113","article-title":"Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines","volume":"61","author":"Garwicz","year":"1997","journal-title":"J Leukoc Biol"},{"key":"2022011223172865900_b3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/jmbi.1996.0458","article-title":"The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies","volume":"261","author":"Fujinaga","year":"1996","journal-title":"J Mol Biol"},{"key":"2022011223172865900_b4","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.1016\/S0021-9258(18)92854-1","article-title":"Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties","volume":"266","author":"Rao","year":"1991","journal-title":"J Biol Chem"},{"key":"2022011223172865900_b5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","article-title":"International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)","volume":"111","author":"Savige","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"2022011223172865900_b6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","article-title":"Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?","volume":"285","author":"Davies","year":"1982","journal-title":"Br Med J Clin Res Ed"},{"key":"2022011223172865900_b7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"The TH: autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"1","author":"Van Der Woude","year":"1985","journal-title":"Lancet"},{"key":"2022011223172865900_b8","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.1989.00390110055012","article-title":"Association between active Wegener's granulomatosis and anticytoplasmic antibodies","volume":"149","author":"Cohen Tervaert","year":"1989","journal-title":"Arch Intern Med"},{"key":"2022011223172865900_b9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1994.239","article-title":"Anti-neutrophil cytoplasmic antibodies. current diagnostic and pathophysiological potential","volume":"46","author":"Kallenberg","year":"1994","journal-title":"Kidney Int"},{"key":"2022011223172865900_b10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.1990.48","article-title":"Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis","volume":"37","author":"Cohen Tervaert","year":"1990","journal-title":"Kidney Int"},{"key":"2022011223172865900_b11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2249.1995.tb05577.x","article-title":"Screening for anti-neutrophil cytoplasmic antibodies (ANCA) is indirect immunofluorescence the method of choice?","volume":"99","author":"Baslund","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2022011223172865900_b12","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1046\/j.1523-1755.1998.00873.x","article-title":"Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody","volume":"53","author":"Westman","year":"1998","journal-title":"Kidney Int"},{"key":"2022011223172865900_b13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2796.2002.00939.x","article-title":"Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis","volume":"251","author":"Gisslen","year":"2002","journal-title":"J Intern Med"},{"key":"2022011223172865900_b14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2249.2001.01420.x","article-title":"Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site","volume":"123","author":"Griffith","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"2022011223172865900_b15","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.4049\/jimmunol.152.9.4722","article-title":"Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis","volume":"152","author":"Williams","year":"1994","journal-title":"J Immunol"},{"key":"2022011223172865900_b16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1523-1755.2001.00475.x","article-title":"Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides","volume":"59","author":"Van Der Geld","year":"2001","journal-title":"Kidney Int"},{"key":"2022011223172865900_b17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2249.1995.tb06644.x","article-title":"Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies","volume":"102","author":"Chang","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2022011223172865900_b18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1523-1755.1999.055003936.x","article-title":"Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease","volume":"55","author":"Hellmark","year":"1999","journal-title":"Kidney Int"},{"key":"2022011223172865900_b19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0014-5793(96)00669-2","article-title":"Recombinant human proteinase 3, the Wegener's autoantigen, expressed in HMC-1 cells is enzymatically active and recognized by c-ANCA","volume":"390","author":"Specks","year":"1996","journal-title":"FEBS Lett"},{"key":"2022011223172865900_b20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2249.1997.tb08325.x","article-title":"Recombinant proteinase 3 (Wegener's antigen) expressed in Pichia pastoris is functionally active and is recognized by patient sera","volume":"110","author":"Harmsen","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"2022011223172865900_b21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/bbrc.1996.0224","article-title":"Expression of the human autoantigen of Wegener's granulomatosis (PR3) in a baculovirus expression system","volume":"219","author":"Szymkowiak","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"2022011223172865900_b22","first-page":"249","article-title":"Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies","volume":"3","author":"Sommarin","year":"1995","journal-title":"Exp Nephrol"},{"key":"2022011223172865900_b23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-1759(97)00203-2","article-title":"Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA\/PR3 immunecomplexes","volume":"211","author":"Sun","year":"1998","journal-title":"J Immunol Meth"},{"key":"2022011223172865900_b24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/03008209109029159","article-title":"Characterization of monoclonal antibodies to the globular domain of collagen IV","volume":"25","author":"Johansson","year":"1991","journal-title":"Connect Tissue Res"},{"key":"2022011223172865900_b25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(97)00418-3","article-title":"Cloning and functional expression of the murine homologue of proteinase 3: implications for the design of murine models of vasculitis","volume":"408","author":"Jenne","year":"1997","journal-title":"FEBS Lett"},{"key":"2022011223172865900_b26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-1119(89)90358-2","article-title":"Site-directed mutagenesis by overlap extension using the polymerase chain reaction","volume":"77","author":"Ho","year":"1989","journal-title":"Gene"},{"key":"2022011223172865900_b27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0003-2697(81)90281-5","article-title":"\u2018Western blotting\u2019. electrophoretic transfer of proteins from sodium dodecyl sulfate \u2013 polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A","volume":"112","author":"Burnette","year":"1981","journal-title":"Anal Biochem"},{"key":"2022011223172865900_b28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","article-title":"Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement","volume":"9","author":"Westman","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2022011223172865900_b29","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011223172865900_b30","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"2022011223172865900_b31","doi-asserted-by":"crossref","first-page":"25862","DOI":"10.1074\/jbc.274.36.25862","article-title":"Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies","volume":"274","author":"Hellmark","year":"1999","journal-title":"J Biol Chem"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2004.02314.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/135\/1\/164\/42145222\/j.1365-2249.2004.02314.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/135\/1\/164\/42145222\/j.1365-2249.2004.02314.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T16:55:55Z","timestamp":1682614555000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/135\/1\/164\/6469533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12,16]]},"published-print":{"date-parts":[[2003,12,16]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02314.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2004,1]]},"published":{"date-parts":[[2003,12,16]]}}}